Skip to search formSkip to main contentSkip to account menu
Guidelines for the management of actinic keratoses.
TLDR
These guidelines attempt to cover clinical practice across Europe and should be regarded as a set of suggestions for care for actinic keratoses Europe-wide.
View on PubMed
Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification
TLDR
An AK classification system is recommended that describes these lesions as squamous cell carcinomas (SCCs), using the terminology ‘ early in situ SCC Type AK I’, ‘early in situSCC type AK II’ and ‘in situ S CC Type AK III’ to give clinicians better guidance for diagnosis and specific treatment recommendations.
View on Wiley
Guidelines for the Management of Squamous Cell Carcinoma in Organ Transplant Recipients
TLDR
Gauges developed for the treatment of skin cancer in OTRs, supported by the best available data and collective clinical experience, may assist in the management of O TRs with SCC.
View on Wolters Kluwer
Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today?
TLDR
Although the threshold of skin cancer necessitating revision of immunosuppression is debated, this measure should be envisaged at the occurrence of the first SCC, or in case of multiple non‐SCC NMSC.
View on Wiley
Development of a treatment algorithm for actinic keratoses: a European Consensus.
TLDR
An algorithm designed to assist physicians with their treatment decisions, giving recommendations for both field directed and lesion directed treatment ofActinic keratoses is described, for the first time, a summary of European best practice recommendations for the treatment of AK.
View on PubMed
Human Papillomaviruses and Non-Melanoma Skin Cancer: Basic Virology and Clinical Manifestations
TLDR
Specific EV/cutaneous HPV types as co-factors in association with UV-radiation and the immune system seem to be involved in the early pathogenesis of cutaneous SCC.
View PDF
A randomised study of topical 5% imiquimod vs. topical 5‐fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including…
Background  Actinic keratoses (AK) frequently occur on sun‐exposed skin and are considered as in situ squamous cell carcinoma. To date, no treatment algorithm exists for first or second line…
View on Wiley
Epidemiology and aetiology of basal cell carcinoma
TLDR
This review elucidates the risk factors for the development and for the progression of BCC leading to an improved understanding of this tumour.
View on Wiley
Low‐dose 5‐fluorouracil in combination with salicylic acid as a new lesion‐directed option to treat topically actinic keratoses: histological and clinical study results
Background  Actinic keratoses (AKs) arise after chronic sun exposure. Because long‐term ultraviolet (UV) damage may induce proliferation of atypical keratinocytes, treatment of AKs is recommended.
View on Wiley
Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling
TLDR
This study examined and identified differentially expressed genes in cutaneous squamous cell carcinoma (SCC) through hybridization with Affymetrix HG-U133A microarray technology containing 22,283 genes.
View on Springer
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License